These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25773831)

  • 1. Association between the NQO1 C609T polymorphism with hepatocellular carcinoma risk in the Chinese population.
    Zhao H; Zou LW; Zheng SS; Geng XP
    Asian Pac J Cancer Prev; 2015; 16(5):1821-5. PubMed ID: 25773831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the NQO1 C609T polymorphism with Alzheimer's disease in Chinese populations: a meta-analysis.
    Luo J; Li S; Qin X; Peng Q; Liu Y; Yang S; Qin X; Xiong Y; Zeng Z
    Int J Neurosci; 2016; 126(3):199-204. PubMed ID: 25562627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NQO1 C609T polymorphism and hepatocellular carcinoma risk.
    Fan Y; Hu D; Feng B; Wang W
    Tumour Biol; 2014 Aug; 35(8):7343-50. PubMed ID: 24532470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis.
    Zhao HY; Gu Y; Yi YX
    Tumour Biol; 2014 Mar; 35(3):2199-203. PubMed ID: 24142529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
    Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
    Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between hepatocellular carcinoma and the interaction between NQO1 polymorphisms and environmental factors].
    Tan SK; Qiu XQ; Tang GF; Wang WW; Liu S
    Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):833-7. PubMed ID: 23206302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between NQO1 C609T polymorphism and colorectal cancer risk.
    Wang Y; Zhang G; Luo Y
    Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
    Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
    Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
    Yadav U; Kumar P; Rai V
    Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between NQO1 C609T polymorphism and prostate cancer risk.
    Sun Z; Cui Y; Pei J; Fan Z
    Tumour Biol; 2014 Aug; 35(8):7993-8. PubMed ID: 24838947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
    Gong M; Yi Q; Wang W
    Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
    Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
    Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.
    Li C; Zhou Y
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):873-81. PubMed ID: 24488035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between TGF-β1 polymorphisms and hepatocellular carcinoma risk: a meta-analysis.
    Guo Y; Zang C; Li Y; Yuan L; Liu Q; Zhang L; Li S
    Genet Test Mol Biomarkers; 2013 Nov; 17(11):814-20. PubMed ID: 24016252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.
    Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z
    Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk.
    Li C; Liu Y; Wei S; Zhou Y
    Pediatr Blood Cancer; 2014 May; 61(5):771-7. PubMed ID: 24474393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis.
    Liu Y; Zhang D
    Asian Pac J Cancer Prev; 2011; 12(11):3091-5. PubMed ID: 22393995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
    Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
    BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of the association between GSTP1 gene Ile105Val polymorphism and susceptibility to hepatocellular carcinoma.
    Zhao Y; Wang Q; Deng X; Shi P; Wang Z
    Tumour Biol; 2013 Aug; 34(4):2121-6. PubMed ID: 23765758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.